-
1
-
-
0017361403
-
The effects of psychotropic drugs on human behaviour
-
Wesnes, K.A., The effects of psychotropic drugs on human behaviour. Mod. Probl. Pharmacopsychiatry 12 (1977), 37–58.
-
(1977)
Mod. Probl. Pharmacopsychiatry
, vol.12
, pp. 37-58
-
-
Wesnes, K.A.1
-
2
-
-
0025981522
-
The cognitive drug research computerised assessment system for demented patients: a validation study
-
Simpson, P.M., Surmon, D.J., Wesnes, K.A., Wilcock, G.R., The cognitive drug research computerised assessment system for demented patients: a validation study. Int. J. Geriatr. Psychopharmacol. 6 (1991), 95–102.
-
(1991)
Int. J. Geriatr. Psychopharmacol.
, vol.6
, pp. 95-102
-
-
Simpson, P.M.1
Surmon, D.J.2
Wesnes, K.A.3
Wilcock, G.R.4
-
3
-
-
0001003915
-
A computerised system for the assessment of drug-induced performance changes in young elderly or demented populations
-
Simpson, P.M., Wesnes, K.A., Christmas, L, A computerised system for the assessment of drug-induced performance changes in young elderly or demented populations. Br. J. Clin. Pharmacol. 27 (1989), 711P–712P.
-
(1989)
Br. J. Clin. Pharmacol.
, vol.27
, pp. 711P-712P
-
-
Simpson, P.M.1
Wesnes, K.A.2
Christmas, L.3
-
4
-
-
27544484649
-
The relationships between P300 and cognitive processing in simple and choice reaction tasks
-
McClelland, G.R., Wesnes, K.A., The relationships between P300 and cognitive processing in simple and choice reaction tasks. J. Psychopharmacol., 9, 1995, A39 Suppl.
-
(1995)
J. Psychopharmacol.
, vol.9
, pp. A39
-
-
McClelland, G.R.1
Wesnes, K.A.2
-
5
-
-
0030460306
-
The utility of clinical trial batteries in the measurement of Alzheimer's and Huntington's dementia
-
Mohr, E, Walker, D, Randolph, C, Sampson, M, Mendis, T, The utility of clinical trial batteries in the measurement of Alzheimer's and Huntington's dementia. Int. Psychogeriatr. 3 (1996), 397–411.
-
(1996)
Int. Psychogeriatr.
, vol.3
, pp. 397-411
-
-
Mohr, E.1
Walker, D.2
Randolph, C.3
Sampson, M.4
Mendis, T.5
-
6
-
-
0028938014
-
The Cognitive Drug Research computerised assessment system in the evaluation of early dementia—is speed of the essence?
-
Nicholl, C.G., Lynch, S, Kelly, C.A., White, L, Simpson, L, Simpson, P.M., Wesnes, K.A., Pitt, B.M.N., The Cognitive Drug Research computerised assessment system in the evaluation of early dementia—is speed of the essence?. Int. J. Geriatr. Psychopharmacol. 10 (1995), 199–206.
-
(1995)
Int. J. Geriatr. Psychopharmacol.
, vol.10
, pp. 199-206
-
-
Nicholl, C.G.1
Lynch, S.2
Kelly, C.A.3
White, L.4
Simpson, L.5
Simpson, P.M.6
Wesnes, K.A.7
Pitt, B.M.N.8
-
7
-
-
4243286970
-
Validity and utility of the CDR computerised cognitive assessment system: a review following 15 years of use
-
Ward, T, Wesnes, K.A., Validity and utility of the CDR computerised cognitive assessment system: a review following 15 years of use. J. Psychopharmacol., 13(Suppl. A), 1999, A25.
-
(1999)
J. Psychopharmacol.
, vol.13
, pp. A25
-
-
Ward, T.1
Wesnes, K.A.2
-
8
-
-
4243350118
-
Cognitive effects of single doses of ME3127, a novel anxiolytic in volunteers
-
Jones, S, Jensen, N.O., Oliver, S, Wesnes, K.A., Cognitive effects of single doses of ME3127, a novel anxiolytic in volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A27.
-
(1999)
J. Psychopharmacol.
, vol.13
, pp. A27
-
-
Jones, S.1
Jensen, N.O.2
Oliver, S.3
Wesnes, K.A.4
-
9
-
-
4243350118
-
Cognitive effects of multiple doses of ME3127, a novel anxiolytic, in volunteers
-
Pincock, C, Jensen, N.O., Oliver, S, Wesnes, K.A., Jones, S, Cognitive effects of multiple doses of ME3127, a novel anxiolytic, in volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A27.
-
(1999)
J. Psychopharmacol.
, vol.13
, pp. A27
-
-
Pincock, C.1
Jensen, N.O.2
Oliver, S.3
Wesnes, K.A.4
Jones, S.5
-
10
-
-
27544490457
-
Cognitive effects of NS2389, a serotonin reuptake inhibitor, in healthy volunteers
-
Russell-Duff, K, Jensen, N.O., Mooney, P, Wesnes, K.A., Cognitive effects of NS2389, a serotonin reuptake inhibitor, in healthy volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A27.
-
(1999)
J. Psychopharmacol.
, vol.13
, pp. A27
-
-
Russell-Duff, K.1
Jensen, N.O.2
Mooney, P.3
Wesnes, K.A.4
-
11
-
-
0002739064
-
The cognitive effects of single and multiple doses of UK 76,654, a selective M3 muscarinic antagonist in healthy volunteers
-
McEwen, J, Wesnes, K.A., Rapeport, W.G., Williams, S, The cognitive effects of single and multiple doses of UK 76,654, a selective M3 muscarinic antagonist in healthy volunteers. Eur. J. Clin. Invest., 25(Suppl. 2), 1995, A64.
-
(1995)
Eur. J. Clin. Invest.
, vol.25
, pp. A64
-
-
McEwen, J.1
Wesnes, K.A.2
Rapeport, W.G.3
Williams, S.4
-
12
-
-
0028341641
-
Single dose human pharmacology of umespirone
-
Holland, R.L., Wesnes, K.A., Dietrich, B, Single dose human pharmacology of umespirone. Eur. J. Clin. Pharmacol. 46 (1994), 461–468.
-
(1994)
Eur. J. Clin. Pharmacol.
, vol.46
, pp. 461-468
-
-
Holland, R.L.1
Wesnes, K.A.2
Dietrich, B.3
-
13
-
-
0342649641
-
A comparison of the cognitive effects of DU29894, sulpiride, haloperidol and a selective 5HT1A agonist in normal volunteers
-
Wesnes, K.A., de Koning, P, Dietrich, B, A comparison of the cognitive effects of DU29894, sulpiride, haloperidol and a selective 5HT1A agonist in normal volunteers. Eur. J. Clin. Invest., 25(Suppl. 2), 1995, A64.
-
(1995)
Eur. J. Clin. Invest.
, vol.25
, pp. A64
-
-
Wesnes, K.A.1
de Koning, P.2
Dietrich, B.3
-
14
-
-
0032998303
-
A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers
-
Beuzen, J.-N., Taylor, N, Wesnes, K, Wood, A, A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers. J. Psychopharmacol. 13 (1999), 152–158.
-
(1999)
J. Psychopharmacol.
, vol.13
, pp. 152-158
-
-
Beuzen, J.-N.1
Taylor, N.2
Wesnes, K.3
Wood, A.4
-
15
-
-
26144462900
-
Cognitive function is unaffected by remacemide at therapeutically relevant single doses
-
Lockton, J.A., Cole, G, Hammersley, M, Wesnes, K.A., Cognitive function is unaffected by remacemide at therapeutically relevant single doses. J. Psychopharmacol., 12(Supplement A), 1998, A41.
-
(1998)
J. Psychopharmacol.
, vol.12
, pp. A41
-
-
Lockton, J.A.1
Cole, G.2
Hammersley, M.3
Wesnes, K.A.4
-
16
-
-
26144442419
-
Remacemide does not affect cognitive function following multiple dosing
-
Lockton, J.A., Wesnes, K.A., Yeates, N, Rolan, P, Diggory, G, Remacemide does not affect cognitive function following multiple dosing. J. Psychopharmacol., 12(Supplement A), 1998, A41.
-
(1998)
J. Psychopharmacol.
, vol.12
, pp. A41
-
-
Lockton, J.A.1
Wesnes, K.A.2
Yeates, N.3
Rolan, P.4
Diggory, G.5
-
17
-
-
4243882084
-
Cognitive effects of NS2330, a novel monoamine reuptake inhibitor, in volunteers
-
Wills, K, Jensen, N.O., Oliver, S, Wesnes, K.A., Cognitive effects of NS2330, a novel monoamine reuptake inhibitor, in volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A27.
-
(1999)
J. Psychopharmacol.
, vol.13
, pp. A27
-
-
Wills, K.1
Jensen, N.O.2
Oliver, S.3
Wesnes, K.A.4
-
18
-
-
4244020303
-
First in man cognitive effects of NS2330, a novel monoamine reuptake inhibitor, in volunteers
-
Jones, S, Jensen, N.O., Oliver, S, Wesnes, K.A., First in man cognitive effects of NS2330, a novel monoamine reuptake inhibitor, in volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A26.
-
(1999)
J. Psychopharmacol.
, vol.13
, pp. A26
-
-
Jones, S.1
Jensen, N.O.2
Oliver, S.3
Wesnes, K.A.4
-
19
-
-
4243212877
-
First cognitive effects of NS2359, a noradrenaline, dopamine and serotonin reuptake inhibitor, in volunteers
-
Bosworth, J, Jensen, N.O., Oliver, S, Wesnes, K.A., First cognitive effects of NS2359, a noradrenaline, dopamine and serotonin reuptake inhibitor, in volunteers. J. Psychopharmacol., 13(Suppl. A), 1999, A26.
-
(1999)
J. Psychopharmacol.
, vol.13
, pp. A26
-
-
Bosworth, J.1
Jensen, N.O.2
Oliver, S.3
Wesnes, K.A.4
-
20
-
-
0001045856
-
Phase I studies of GTS-21 to assess the safety, tolerability, PK and effects on measures of cognitive function in normal volunteers
-
Kitagawa, H, Moriyama, A, Takenouchi, T, Wesnes, K.A., Kramer, W, Clody, D.E., Phase I studies of GTS-21 to assess the safety, tolerability, PK and effects on measures of cognitive function in normal volunteers. Neurobiol. Aging, 19(Supplement 2), 1998, S182.
-
(1998)
Neurobiol. Aging
, vol.19
, pp. S182
-
-
Kitagawa, H.1
Moriyama, A.2
Takenouchi, T.3
Wesnes, K.A.4
Kramer, W.5
Clody, D.E.6
-
21
-
-
0001766901
-
Smoking, nicotine and human performance
-
A Smith D Jones Academic Press London
-
Wesnes, K.A., Parrott, A, Smoking, nicotine and human performance. Smith, A, Jones, D, (eds.) Handbook of Human Performance, vol. 2, 1992, Academic Press, London, 127–167.
-
(1992)
Handbook of Human Performance
, vol.2
, pp. 127-167
-
-
Wesnes, K.A.1
Parrott, A.2
-
22
-
-
85023123083
-
Cognitive enhancement with physostigmine in young volunteers
-
Annual Meeting of the British Association for Psychopharmacology, Cambridge, July 1994
-
Wesnes, K.A., Simpson, P.M., Thompson, S, Wallnöfer, A, Dingemanse, J, McClelland, G, Malek, N, Cognitive enhancement with physostigmine in young volunteers., Annual Meeting of the British Association for Psychopharmacology, Cambridge, July 1994, 1994.
-
(1994)
-
-
Wesnes, K.A.1
Simpson, P.M.2
Thompson, S.3
Wallnöfer, A.4
Dingemanse, J.5
McClelland, G.6
Malek, N.7
-
23
-
-
0032900133
-
Relationships among age, CS–US interval and neuropsychological test performance
-
Woodruff-Pak, D.S., Jaegar, M.E., Golman, C, Wesnes, K.A., Relationships among age, CS–US interval and neuropsychological test performance. Neuropsychology 13 (1999), 90–102.
-
(1999)
Neuropsychology
, vol.13
, pp. 90-102
-
-
Woodruff-Pak, D.S.1
Jaegar, M.E.2
Golman, C.3
Wesnes, K.A.4
-
24
-
-
84959180457
-
Oxygen administration and cognitive performance in the elderly: a case of selective enhancement
-
Moss, M.C., Scholey, A.B., Neave, N, Stubbs, P, Wesnes, K.A., Oxygen administration and cognitive performance in the elderly: a case of selective enhancement. J. Psychopharmacol., 12(Supplement A), 1998, A41.
-
(1998)
J. Psychopharmacol.
, vol.12
, pp. A41
-
-
Moss, M.C.1
Scholey, A.B.2
Neave, N.3
Stubbs, P.4
Wesnes, K.A.5
-
25
-
-
0002936105
-
Pharmacodynamic effects of a repeated oral administration of four dose levels of S 12024-2 in 36 elderly volunteers
-
Wesnes, K, Neuman, E, de Wilde, H.J.G., Malbezin, M, Castagné, I, Crijns, H.J.M.J, Jonkman, J.H.G., Guez, D, Pharmacodynamic effects of a repeated oral administration of four dose levels of S 12024-2 in 36 elderly volunteers. Neurobiol. Aging, 15, 1994, S100.
-
(1994)
Neurobiol. Aging
, vol.15
, pp. S100
-
-
Wesnes, K.1
Neuman, E.2
de Wilde, H.J.G.3
Malbezin, M.4
Castagné, I.5
Crijns, H.J.M.J.6
Jonkman, J.H.G.7
Guez, D.8
-
26
-
-
0026390289
-
First clinical impressions with an ACTH analogue (HOE 427) in the treatment of Alzheimer's disease
-
Siegfried, K, First clinical impressions with an ACTH analogue (HOE 427) in the treatment of Alzheimer's disease. Ann. N. Y. Acad. Sci. 640 (1991), 260–283.
-
(1991)
Ann. N. Y. Acad. Sci.
, vol.640
, pp. 260-283
-
-
Siegfried, K.1
-
27
-
-
0000892827
-
Flesinoxan improves cognition in the elderly
-
van Harten, J, Olff, M, Wesnes, K.A., Strobel, W, Flesinoxan improves cognition in the elderly. Eur. Neuropsychopharmacol., 6(Suppl. 3), 1996, 186.
-
(1996)
Eur. Neuropsychopharmacol.
, vol.6
, pp. 186
-
-
van Harten, J.1
Olff, M.2
Wesnes, K.A.3
Strobel, W.4
-
28
-
-
0024388506
-
The effects of moclobemide on cognition
-
Wesnes, K, Simpson, P, Christmas, L, Anand, R, McClelland, G.R., The effects of moclobemide on cognition. J. Neural Transm. 29 (1989), 91–102.
-
(1989)
J. Neural Transm.
, vol.29
, pp. 91-102
-
-
Wesnes, K.1
Simpson, P.2
Christmas, L.3
Anand, R.4
McClelland, G.R.5
-
29
-
-
0030757001
-
Moxonidine and cognitive function: interactions with moclobemide and lorazepam
-
Wesnes, K, Simpson, P.M., Jansson, B, Grahnén, A, Weimann, H.-J., Küppers, H, Moxonidine and cognitive function: interactions with moclobemide and lorazepam. Eur. J. Clin. Pharmacol. 52 (1997), 351–358.
-
(1997)
Eur. J. Clin. Pharmacol.
, vol.52
, pp. 351-358
-
-
Wesnes, K.1
Simpson, P.M.2
Jansson, B.3
Grahnén, A.4
Weimann, H.-J.5
Küppers, H.6
-
30
-
-
0033984631
-
Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers
-
Wesnes, K.A., Garratt, C, Wickens, M, Gudgeon, A, Oliver, S, Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers. Br. J. Clin. Pharmacol. 49 (2000), 110–117.
-
(2000)
Br. J. Clin. Pharmacol.
, vol.49
, pp. 110-117
-
-
Wesnes, K.A.1
Garratt, C.2
Wickens, M.3
Gudgeon, A.4
Oliver, S.5
-
31
-
-
27544495818
-
Absence of interaction between SB-202026 and alcohol in healthy elderly volunteers
-
Semos, M.L., Fitzpatrick, K, Jones, R.W., Mann, J.B., Ramezani, E, Wesnes, K.A., Absence of interaction between SB-202026 and alcohol in healthy elderly volunteers. J. Psychopharmacol., 12(Supplement A), 1998, A40.
-
(1998)
J. Psychopharmacol.
, vol.12
, pp. A40
-
-
Semos, M.L.1
Fitzpatrick, K.2
Jones, R.W.3
Mann, J.B.4
Ramezani, E.5
Wesnes, K.A.6
-
32
-
-
0032973812
-
A double-blind, placebo-controlled trial of intravenous flumazenil in Alzheimer's disease
-
Templeton, L, Barker, A, Wesnes, K, Wilkinson, D, A double-blind, placebo-controlled trial of intravenous flumazenil in Alzheimer's disease. Hum. Psychopharmacol. 14 (1999), 239–245.
-
(1999)
Hum. Psychopharmacol.
, vol.14
, pp. 239-245
-
-
Templeton, L.1
Barker, A.2
Wesnes, K.3
Wilkinson, D.4
-
33
-
-
0021170003
-
The separate and combined effects of scopolamine and nicotine on human information processing
-
Wesnes, K, Revell, A, The separate and combined effects of scopolamine and nicotine on human information processing. Psychopharmacology 84 (1984), 5–11.
-
(1984)
Psychopharmacology
, vol.84
, pp. 5-11
-
-
Wesnes, K.1
Revell, A.2
-
34
-
-
0025381490
-
Group report 3: early clinical testing of cognition enhancers: prediction of efficacy
-
Hall, S.T., Puech, A, Schaffler, K, Wesnes, K, Gamzu, E.R., Group report 3: early clinical testing of cognition enhancers: prediction of efficacy. Pharmacopsychiatry 23 (1990), 57–60.
-
(1990)
Pharmacopsychiatry
, vol.23
, pp. 57-60
-
-
Hall, S.T.1
Puech, A.2
Schaffler, K.3
Wesnes, K.4
Gamzu, E.R.5
-
35
-
-
0343021915
-
Can scopolamine produce a model of the memory deficits seen in ageing and dementia?
-
M.M Gruneberg P.E Morris R.N Sykes Wiley Chichester
-
Wesnes, K.A., Simpson, P.M., Can scopolamine produce a model of the memory deficits seen in ageing and dementia?. Gruneberg, M.M., Morris, P.E., Sykes, R.N., (eds.) Practical Aspects of Memory: Current Research and Issues. Volume 2: Clinical and Educational Implications, 1988, Wiley, Chichester, 236–242.
-
(1988)
Practical Aspects of Memory: Current Research and Issues. Volume 2: Clinical and Educational Implications
, pp. 236-242
-
-
Wesnes, K.A.1
Simpson, P.M.2
-
36
-
-
85023073269
-
The ‘scopolamine model of some core cognitive deficits seen in Alzheimer's disease’: same model, slightly different name
-
Wesnes, K.A., The ‘scopolamine model of some core cognitive deficits seen in Alzheimer's disease’: same model, slightly different name. J. Psychopharmacol., 9, 1995, A7 Suppl.
-
(1995)
J. Psychopharmacol.
, vol.9
, pp. A7
-
-
Wesnes, K.A.1
-
37
-
-
0026389770
-
Cholinesterase inhibition in the scopolamine model of dementia
-
Wesnes, K.A., Simpson, P.M., White, L, Pinker, S, Jertz, G, Murphy, M, Siegfried, K, Cholinesterase inhibition in the scopolamine model of dementia. Ann. N. Y. Acad. Sci. 640 (1991), 268–271.
-
(1991)
Ann. N. Y. Acad. Sci.
, vol.640
, pp. 268-271
-
-
Wesnes, K.A.1
Simpson, P.M.2
White, L.3
Pinker, S.4
Jertz, G.5
Murphy, M.6
Siegfried, K.7
-
38
-
-
0031955434
-
Effects of physostigmine on scopolamine-induced changes in quantitative electroencephalogram and cognitive performance
-
Ebert, U, Oertel, R, Wesnes, K.A., Kirch, W, Effects of physostigmine on scopolamine-induced changes in quantitative electroencephalogram and cognitive performance. Hum. Psychopharmacol. 13 (1998), 199–210.
-
(1998)
Hum. Psychopharmacol.
, vol.13
, pp. 199-210
-
-
Ebert, U.1
Oertel, R.2
Wesnes, K.A.3
Kirch, W.4
-
39
-
-
0027748339
-
Pharmacodynamic and early clinical studies with velnacrine
-
Siegfried, K.R., Pharmacodynamic and early clinical studies with velnacrine. Acta Neurol. Scand. 149 (1993), 26–28 Suppl.
-
(1993)
Acta Neurol. Scand.
, vol.149
, pp. 26-28
-
-
Siegfried, K.R.1
-
40
-
-
0025673863
-
The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers
-
Wesnes, K.A., Anand, R, Simpson, P.M., Christmas, L, The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers. J. Psychopharmacol. 4 (1990), 219–232.
-
(1990)
J. Psychopharmacol.
, vol.4
, pp. 219-232
-
-
Wesnes, K.A.1
Anand, R.2
Simpson, P.M.3
Christmas, L.4
-
41
-
-
0023228040
-
The use of a scopolamine model to study the nootropic effects of tenilsetam (CAS 997) in man
-
Wesnes, K, Simpson, P.M., Kidd, A.G., The use of a scopolamine model to study the nootropic effects of tenilsetam (CAS 997) in man. Med. Sci. Res. 15 (1987), 1063–1064.
-
(1987)
Med. Sci. Res.
, vol.15
, pp. 1063-1064
-
-
Wesnes, K.1
Simpson, P.M.2
Kidd, A.G.3
-
42
-
-
0025120689
-
Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of ageing and dementia
-
Wesnes, K, Anand, R, Lorscheid, T, Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of ageing and dementia. Acta Psychiatr. Scand. 82 (1990), 71–72.
-
(1990)
Acta Psychiatr. Scand.
, vol.82
, pp. 71-72
-
-
Wesnes, K.1
Anand, R.2
Lorscheid, T.3
-
43
-
-
27544466859
-
FK960 antagonises the memory impairments produced by scopolamine in healthy volunteers
-
Wesnes, K.A., Ramezani, E, Oliver, S, FK960 antagonises the memory impairments produced by scopolamine in healthy volunteers. J. Psychopharmacol., 11, 1997, A57 Suppl.
-
(1997)
J. Psychopharmacol.
, vol.11
, pp. A57
-
-
Wesnes, K.A.1
Ramezani, E.2
Oliver, S.3
-
44
-
-
0000121224
-
The effects of D-cycloserine, a glycine agonist, in a human model of the cognitive deficits associated with ageing and dementia
-
Wesnes, K.A., Jones, R.W., Kirby, J, The effects of D-cycloserine, a glycine agonist, in a human model of the cognitive deficits associated with ageing and dementia. Br. J. Clin. Pharmacol. 31 (1991), 577P–578P.
-
(1991)
Br. J. Clin. Pharmacol.
, vol.31
, pp. 577P-578P
-
-
Wesnes, K.A.1
Jones, R.W.2
Kirby, J.3
-
45
-
-
0344503022
-
D-Cycloserine antagonises scopolamine induced memory impairment and improves attention in the elderly
-
Wesnes, K, Jones, R, Kirby, J, Curtis, L, D-Cycloserine antagonises scopolamine induced memory impairment and improves attention in the elderly. Biol. Psychiatry 29 (1991), 700S–701S.
-
(1991)
Biol. Psychiatry
, vol.29
, pp. 700S-701S
-
-
Wesnes, K.1
Jones, R.2
Kirby, J.3
Curtis, L.4
-
46
-
-
0028842708
-
Evaluation of cycloserine in the treatment of Alzheimer's disease
-
Fakouhi, T.D., Jhee, S.S., Sramek, J.J., Benes, C, Schwartz, P, Hantsburger, G, Herting, R, Swabb, E.A., Cutler, N.R., Evaluation of cycloserine in the treatment of Alzheimer's disease. J. Geriatr. Psychiatry. Neurol. 8 (1995), 226–230.
-
(1995)
J. Geriatr. Psychiatry. Neurol.
, vol.8
, pp. 226-230
-
-
Fakouhi, T.D.1
Jhee, S.S.2
Sramek, J.J.3
Benes, C.4
Schwartz, P.5
Hantsburger, G.6
Herting, R.7
Swabb, E.A.8
Cutler, N.R.9
-
47
-
-
4243574696
-
Development and validation of a system for evaluating cognitive functioning over the telephone for use in late phase drug development
-
Wesnes, K.A., Ward, T, Ayre, G, Pincock, C, Development and validation of a system for evaluating cognitive functioning over the telephone for use in late phase drug development. Eur. Neuropsychopharmacol., 9(Suppl. 5), 1999, S368.
-
(1999)
Eur. Neuropsychopharmacol.
, vol.9
, pp. S368
-
-
Wesnes, K.A.1
Ward, T.2
Ayre, G.3
Pincock, C.4
-
48
-
-
85023137853
-
Validation of a telephone cognitive assessment battery in chronic fatigue syndrome (CFS)
-
McCue, P, Scholey, A.B., Wesnes, K.A., Herman, C, Validation of a telephone cognitive assessment battery in chronic fatigue syndrome (CFS). J. Psychopharmacol., 14, 2000, A43.
-
(2000)
J. Psychopharmacol.
, vol.14
, pp. A43
-
-
McCue, P.1
Scholey, A.B.2
Wesnes, K.A.3
Herman, C.4
-
49
-
-
85023070410
-
An examination of the time course of cognitive effects resulting from administration of midazolam in routine dental procedures
-
Girdler, N.M., Fairbrother, K, Neave, N, Scholey, A, Hargaden, N, Wesnes, K.A., Engler, J, Rotheram, N.A., An examination of the time course of cognitive effects resulting from administration of midazolam in routine dental procedures. J. Psychopharmacol., 14, 2000, A45.
-
(2000)
J. Psychopharmacol.
, vol.14
, pp. A45
-
-
Girdler, N.M.1
Fairbrother, K.2
Neave, N.3
Scholey, A.4
Hargaden, N.5
Wesnes, K.A.6
Engler, J.7
Rotheram, N.A.8
|